DOI: 10.12890/2024_004494
Atypical pulmonary metastasis of prostate adenocarcinoma: a rare phenomenon
Authors
ajamil1@phsi.us
Keywords
Prostate cancer, metastasis, adenocarcinoma, lymphagitic spread, prostate-specific antigen (PSA), lactate dehydrogenase (LDH)Abstract
Prostate cancer can metastasise to the lung. Most common presentations described in the literature are solitary pulmonary nodules, lymphangitic spread and, rarely, pleural effusion.
We describe a case of prostate adenocarcinoma with diffuse bilateral reticulonodular and lymphangitic pulmonary metastasis, and malignant pleural effusion while being on androgen deprivation therapy.
References
- Meyer A, Mariani RA, Nabhan C. Lymphangitic pulmonary metastases in castrate-resistant prostate adenocarcinoma. Case Rep Med 2012;2012:980920.
- Hsing AW, Tsao L, Devesa SS. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 2000;85:60–67.
- Knight JC, Ray MA, Benzaquen S. Malignant pleural effusion from prostate adenocarcinoma. Respir Med Case Rep 2014;13:24-25.
- Morin ME, MacNealy GA, Tan A, Li YP, Engel G, Henneberry M. Hormonal manipulation of pulmonary metastases from carcinoma of the prostate. Urol Radiol 1982;4:23–27.
- Gorshein E, Burger R, Ferrari A, Mayer T. Dramatic mixed response of lymphangitic pulmonary metastases in newly diagnosed prostate cancer. Urol Ann 2017;9:278–280.
Published
2024-04-22
Issue
Categories
How to Cite
1.
Jamil A, Ali R, Paige A, Miller R, Mistry N, Abbas A, et al. Atypical pulmonary metastasis of prostate adenocarcinoma: a rare phenomenon. EJCRIM [Internet]. 2024 Apr. 22 [cited 2026 Nov. 3];11(5). Available from: https://ejcrim.com/index.php/ejcrim/article/view/4494
